Clinical Trial Update: IORT on Borderline Resectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intraoperative radiation therapy (IORT) for borderline resectable pancreatic cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Resectable Pancreatic Cancer

Drugs mentioned

• Intraoperative Radiation Therapy (IORT)

Snippet

Sponsor: Universita di Verona | Conditions: Borderline Resectable Pancreatic Cancer | Phase 2 | Status: SUSPENDED